![Michael P. Reidy](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael P. Reidy
Keine laufenden Positionen mehr
Profil
Dr. Michael P.
Reidy is Vice President-Research & Development at Vyteris, Inc.
Dr. Reidy was previously employed as a Principal Scientist by Cygnus, Inc.
He received his undergraduate degree from Manhattan College.
Ehemalige bekannte Positionen von Michael P. Reidy
Unternehmen | Position | Ende |
---|---|---|
Cygnus, Inc.
![]() Cygnus, Inc. Medical SpecialtiesHealth Technology Cygnus, Inc. develops and manufactures glucose-monitoring devices. The company develops devices that provide data to individuals and physicians to enable them to manage diabetes. It was founded in 1985 and is headquartered in San Francisco, CA. | Technik-/Wissenschafts-/F&E-Leiter | - |
Vyteris, Inc.
![]() Vyteris, Inc. Pharmaceuticals: MajorHealth Technology Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Michael P. Reidy
Manhattan College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Vyteris, Inc.
![]() Vyteris, Inc. Pharmaceuticals: MajorHealth Technology Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ. | Health Technology |
Polytechnic University | Consumer Services |
Cygnus, Inc.
![]() Cygnus, Inc. Medical SpecialtiesHealth Technology Cygnus, Inc. develops and manufactures glucose-monitoring devices. The company develops devices that provide data to individuals and physicians to enable them to manage diabetes. It was founded in 1985 and is headquartered in San Francisco, CA. | Health Technology |